Anemarrhena asphodeloides
Anemarrhena asphodeloides · Accepted scientific name
Scientific literature: Very Sparse (11 studies) · ★☆☆☆☆
Anemarrhena asphodeloides is a medicinal plant valued for its bioactive compounds, including mangiferin, flavonoids, nyasol, and various steroids. Primarily sourced from the rhizome and root, its 80% ethanol extracts are frequently utilized in pharmacological research. The plant demonstrates significant therapeutic potential through its antidiabetic, antiallergic, antimicrobial, and antiosteoporotic activities. Scientific studies have explored its efficacy in addressing inflammation, managing allergies, and treating acute renal failure. Furthermore, its impact on biological systems is often evaluated using models such as the A549 cell line.
- Synonyms
- Terauchia Anemarrhenifolia
- Common names
- Not available
- Family
- Asparagaceae
- Distribution
- Africa
- Plant Parts
- Rhizome · Root
Classification
Common Names
Anemarrhena asphodeloides is a botanical specimen recognized by a diverse array of regional and linguistic identifiers. It is frequently referred to by the common names Anemarena asfodelowata and anemaréna asfodelovitá. In certain cultural contexts, the plant is known as axlilja or simply as jimo. Additionally, the name hana-suge is often used to identify this specific species. These varied names highlight the plant's widespread presence across different geographical landscapes.
Sources: Catalogue of Life (COL)
Synonyms
Anemarrhena asphodeloides is a botanical species that is frequently identified in scientific literature by its synonym, Terauchia anemarrhenifolia. While these two names may appear distinct to a casual observer, they both refer to the exact same plant. Understanding this nomenclatural relationship is essential for researchers tracking the species across various databases. Such taxonomic overlaps ensure that botanical studies remain consistent even when different naming conventions are applied. Recognizing Terauchia anemarrhenifolia as an alternative label helps clarify its classification within the plant kingdom.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Anemarrhena asphodeloides is a distinctive member of the kingdom Plantae. Within this vast biological realm, the plant is classified under the class Equisetopsida. It belongs to the order Asparagales, showcasing its specific evolutionary lineage. Furthermore, this species is situated within the family Asparagaceae, highlighting its botanical connections. Ultimately, it is defined by its specific genus, Anemarrhena, which distinguishes it from other related species.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asparagales |
| Family | Asparagaceae |
| Genus | Anemarrhena |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Anemarrhena asphodeloides is a plant primarily found throughout the Asia-Temperate region. Its natural distribution is heavily concentrated within the vast territories of China. Specifically, it can be located across the North-Central, South-Central, and Southeast regions of the country. Additionally, the species thrives in more northern areas such as Inner Mongolia and Manchuria. This wide geographic range highlights the plant's ability to adapt to various environments across East Asia.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Anemarrhena asphodeloides is characterized by its distinct growth form as a perennial herb. This plant is entirely self-supporting, maintaining its upright structure within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Anemarrhena asphodeloides is a versatile medicinal plant belonging to the Liliaceae family that has been utilized in traditional East Asian medicine for thousands of years. Scientific research highlights its significant antidiabetic properties, particularly through its ability to act as a potential inhibitor of the $\alpha$-glucosidase enzyme. The plant also demonstrates notable estrogenic activity, making it a subject of interest for studies involving phytoestrogens and hormone-related therapies. Furthermore, its broad pharmacological profile includes antiallergic effects and significant anticancer potential, especially when used in the synthesis of bioactive nanoparticles. Finally, specific compounds isolated from the plant, such as nyasol, have shown promising antifungal activity, particularly when used in synergy with existing azole agents.
Compounds
Anemarrhena asphodeloides is a medicinal plant with a rich history of use in traditional East Asian medicine to treat various ailments. Phytochemical investigations have revealed that the plant contains a diverse array of compounds, including flavonoids and steroids. Among its many active constituents, the plant is known to contain mangiferin, which has demonstrated significant antidiabetic potential. Additionally, the plant contains nyasol, a norlignan that has shown promise in suppressing neuroinflammatory responses and providing antifungal activity. The presence of timosaponin B II further contributes to its pharmacological profile, playing a vital role in enhancing immune responses and providing anti-inflammatory effects.
Conditions
Anemarrhena asphodeloides treats inflammation through its ability to suppress the production of nitric oxide, reactive oxygen species, and pro-inflammatory cytokines. The plant also treats the A549 cell line by facilitating the synthesis of nanoparticles that exhibit specific cytotoxicity and reduced cell migration. In studies of antidiabetic potential, Anemarrhena asphodeloides treats ACE by demonstrating high levels of inhibition. Furthermore, the plant treats AD symptoms by alleviating skin lesions and improving parameters like epidermal thickness and mast cell infiltration. Finally, Anemarrhena asphodeloides treats AD-induced skin inflammation by reducing serum levels of TSLP and locally suppressing the expression of relevant cytokines.
Preparations
Anemarrhena asphodeloides is prepared as extract, often utilized in various research studies to evaluate its medicinal properties. The plant is specifically prepared as rhizomes, which serve as the source for isolating several steroidal glycosides and saponins. Various formulations are used in scientific testing, including the use of 80% ethanol extracts to examine antioxidant capacities. Furthermore, the plant is prepared as A. asphodeloides extract (AAE) to investigate its effects on gut microbiota and pancreatic function in diabetic models. Researchers also utilize AA extract to study its protective potential against acute renal failure and its ability to inhibit intracellular reactive oxygen species.
Parts used
Anemarrhena asphodeloides is a medicinal plant that contains several important underground structures, specifically the rhizome and the root. Scientific research highlights that the rhizome is a primary source of bioactive compounds, including new steroids and glycosides like pseudoprototimosaponin AIII. These components extracted from the rhizome have demonstrated significant biological activities, such as inhibiting α-glucosidase and exerting hypoglycemic effects. Furthermore, advanced analytical methods have been developed to distinguish specific chemical markers between the fibrous root and the rhizome of the plant. Understanding these different plant parts is essential for optimizing the harvest time and increasing the utilization of its valuable medicinal resources.